BMP and Other Activin Receptor Inhibitors: Small Molecules and Peptides
Cellular responses to bone morphogenetic proteins (BMPs) are mediated by the formation of hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. There are seven known type I serine/threonine kinases and five mammalian type II serine/threonine kinase receptors that function in TGF-beta superfamily signal transduction. The type II receptors for TGF-beta and activin bind ligands with high affinity by themselves. In contrast, BMPR-II binding to BMP-2, BMP-4, and BMP-7 is facilitated by the presence of the type I receptor. The type I receptors are also known as activin receptor-like kinases or ALKs.
9 results for "BMP and Other Activin Receptor Inhibitors Small Molecules and Peptides" in Products
Search
Product Action
Conjugates
Low Endotoxin
Sample Size
Reviews
Brand
BMP and Other Activin Receptor Inhibitors: Small Molecules and Peptides
Cellular responses to bone morphogenetic proteins (BMPs) are mediated by the formation of hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. There are seven known type I serine/threonine kinases and five mammalian type II serine/threonine kinase receptors that function in TGF-beta superfamily signal transduction. The type II receptors for TGF-beta and activin bind ligands with high affinity by themselves. In contrast, BMPR-II binding to BMP-2, BMP-4, and BMP-7 is facilitated by the presence of the type I receptor. The type I receptors are also known as activin receptor-like kinases or ALKs.
9 results for "BMP and Other Activin Receptor Inhibitors Small Molecules and Peptides" in Products
Selective inhibitor of TGF-βRI, ALK4 and ALK7
Chemical Name: | 3-(6-Methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-1H-pyrazole-1-carbothioamide |
Purity: | ≥98% (HPLC) |
Potent and selective ALK2 and ALK3 inhibitor; inhibits BMP4 signaling; promotes neural induction of hPSCs
Chemical Name: | 4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline dihydrochloride |
Purity: | ≥98% (HPLC) |
Potent AMPK inhibitor; also BMP type I receptor inhibitor
Alternate Names: | Compound C,BML-275 |
Chemical Name: | 6-[4-[2-(1-Piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)-pyrazolo[1,5-a]pyrimidine dihydrochloride |
Purity: | ≥98% (HPLC) |
Selective ALK2 inhibitor
Chemical Name: | 4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline |
Purity: | ≥98% (HPLC) |
Type 1 BMP receptor inhibitor
Alternate Names: | K 02288a |
Chemical Name: | 3-[(6-Amino-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenol |
Purity: | ≥99% (HPLC) |
Type I BMP receptor inhibitor
Chemical Name: | 4-[6-[4-[2-(4-Morpholinyl)ethoxy]phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline |
Purity: | ≥98% (HPLC) |
Selective inhibitor of TGF-βRI, ALK4 and ALK7
Chemical Name: | 2-[4-(1,3-Benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-5-yl]-6-methyl-pyridine |
Purity: | ≥98% (HPLC) |
Potent and selective ALK1 and ALK2 inhibitor
Alternate Names: | LDN 193719,1lWY,VU0469381 |
Chemical Name: | 5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline |
Purity: | ≥98% (HPLC) |
A 83-01 synthesized to Ancillary Material Grade
Chemical Name: | 3-(6-Methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-1H-pyrazole-1-carbothioamide |
Purity: | ≥98% |